Şeref ŞİMŞEK, Tuba TUNCEL, Ayşen CETEMEN, Tuğba YÜKSEL, M. Fuat GÜRKAN

Quality of Life, Alexithymia, Anxiety and Depression Symptoms among Mothers of Children with Atopic

Atopik dermatit tanılı çocukların anneleri arasında yaşam kalitesi, aleksitimi, depresyon ve anksiyete belirtileri Amaç: AD tanısı alan çocukların annelerinin hayatlarının birçok aşamasının etkilendiği düşünülmektedir. Bu çalışmanın amacı, atopik dermatit (AD) tanısı alan çocukların anneleri ile sağlıklı çocuğa sahip annelerin yaşam kalitesi, anksiyete, depresyon ve aleksitimi düzeyleri arasında fark olup olmadığını araştırmaktır. Yöntem: Çalışmaya Haziran 2012-Temmuz 2013 tarihleri arasında atopik dermatit tanısı alan 34 çocuk annesi ile 35 sağlıklı çocuk annesi katıldı. Araştırmada yaşam kalitesini değerlendirmek için Kısa Form 36 (SF-36) Sağlık Taraması, aleksitimi düzeyi için Toronto Aleksitimi Ölçeği, anksiyete düzeyi için Durumluk ve Sürekli Kaygı Envanteri ve depresyon düzeyini ölçmek için Beck Depresyon Ölçeği kullanıldı. Bulgular: Hasta ve kontrol grupları arasında yaşam kalitesi, anksiyete, depresyon ve aleksitimi açısından anlamlı farklılık saptanmadı (p>0.05). Ayrıca, hastalığın şiddeti ile ölçek puanları arasında gruplar arasında anlamlı farklılık saptanmadı (p>0.05). Sonuç: Hastalığın erken evresinde annenin ruh sağlığının etkilenmediği ileri sürülebilir. Hastalığın ilerleyen dönemlerinde psikolojik etkilenme söz konusu olabilir. Bu nedenle uzun süreli takip çalışmasına gerek duyulmaktadır

Quality of life, alexithymia, anxiety and depression symptoms among mothers of children with atopic dermatitisObjective: The mothers of children diagnosed with atopic dermatitis (AD) may be impacted in many different ways. Aim of the present study was to compare quality of life, anxiety, depression, and alexithymia symptoms between mothers of children diagnosed with AD and mothers of healthy children. Method: The study included 34 mothers of children who were diagnosed with AD between June 2012 and July 2013 and 35 mothers of healthy children. In the study, Short Form 36 (SF-36) Health Survey was used to evaluate quality of life, while the Toronto Alexithymia Scale (TAS) was used to evaluate alexithymia level, the State-Trait Anxiety Inventory (STAI) was used to evaluate anxiety symptoms, and the Beck Depression Scale (BDS) was used to evaluate depression symptoms. Results: There was no statistically significant difference between the mothers of AD patients and control subjects in terms of quality of life, anxiety, depression, and alexithymia. In addition, there was no significant difference in disease severity or symptoms scale scores between the two groups. Conclusion: These results may suggest that mothers' mental health is not affected in the early stage of the disease. In later stages of the disease, mothers of children with AD may become psychologically affected. Longterm follow up studies are required to clarify this distinction

PDF

___

Kondo-Endo K, Ohashi Y, Nakagawa H, Katsunuma T, Ohya Y, Kamibeppu K, Masuko I. Development and validation of a questionnaire measuring quality of life in primary caregivers of children with atopic dermatitis (QPCAD). Br J Dermatol 2009; 161:617-625. [CrossRef]

Ricci G, Bendandi B, Aiazzi R, Patrizi A, Masi M. Three years of Italian experience of an educational program for parents of young children affected by atopic dermatitis: Improving knowledge produces lower anxiety levels in parents of children with atopic dermatitis. Pediatr Dermatol 2009; 26:1-5. [CrossRef]

Howlett S. Emotional dysfunction, child-family relationships and childhood atopic dermatitis. Br J Dermatol 1999; 140:381- 384. [CrossRef]

Rodriguez-Orozco AR, Kanan-Cedeno EG, Guillen Martinez E, Campos Garibay MJ. Family functioning and illness perception of parents of children with atopic dermatitis, living without skin symptoms, but with psychosomatic symptoms. Iran J Allergy Asthma Immunol 2011; 10:61-65.

Abidin R. Parenting Stress Index. Charlottesville, VA: Pediatric Psychology Press; 1992.

Pauli-Pott U, Darui A, Beckmann D. Infants with atopic dermatitis: maternal hopelessness, child-rearing attitudes and perceived infant temperament. Psychother Psychosom 1999; 68:39-45. [CrossRef]

Moore K, David TJ, Murray CS, Child F, Arkwright PD. Effect of childhood eczema and asthma on parental sleep and well-being: a prospective comparative study. Br J Dermatol 2006; 154:514- 518. [CrossRef]

Reid P, Lewis-Jones MS. Sleep difficulties and their management in preschoolers with atopic eczema. Clin Exp Dermatol 1995; 20:38-41. [CrossRef]

Williams HC, Jburney PG, Pembroke AC, Hay RJ. The UK working party's diagnostic criteria for atopic dermatitis. III. Independent hospital validation. Br J Dermatol 1994; 131:406- 416. [CrossRef]

Stalder JF, Taieb A. Severity scoring of atopic dermatitis: the SCORAD index. Dermatology 1993; 186:23-31. [CrossRef]

Kocyigit H, Aydemir O, Olmez N, Nemis A. Reliability and validity of Short Form-36 (SF-36)'s Turkish version. Drug and Treatment 1999; 12:102-106. (Turkish)

Taylor GJ. Recent developments in alexithymia theory and research. Can J Psychiatry 2000; 45:134-142.

Gulec H, Kose S, Gulec MY, Citak S, Evren C, Borckardt J, Sayar K. Reliability and factorial validity of the Turkish version of the 20-item Toronto alexithymia scale (TAS-20). Bull Clin Psychopharmacol 2009; 19:214-220.

Spielberger C, Gorsuch R, Lushene R. Manual for the state- trait anxiety inventory. Palo Alto, ABD: California Consulting Psychologists Press; 1970.

Oner N, LeCompte A. Manual for the State-Trait Anxiety Inventory. Second edition. Istanbul: Bosphorus University Press; 1985. (Turkish)

Hisli N. Validity and reliability of the Beck Depression Inventory for college students. Psychology J 1989; 7:3-13. (Turkish)

Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? J Eur Acad Dermatol Venereol 2002; 16:455-462. [CrossRef]

Ho RCM, Giam YC, Ng TP, Mak A, Goh D, Zhang MWB, Cheak A, Bever HPV. The influence of childhood atopic dermatitis on health of mothers, and its impact on Asian families. Pediatr Allergy Immunol 2010; 21:501-507. [CrossRef]

Walker C, Papadopoulos L, Hussein M. Paediatric eczema and psychosocial morbidity: how does eczema interact with parents' illness beliefs? J Eur Acad Dermatol Venereol 2007; 21:63-67. [CrossRef]

Balkrishnan R, Manuel J, Clarke J, Carroll CL, Housman TS, Fleischer AB Jr. Effects of an episode of specialist care on the impact of childhood atopic dermatitis on the child's family. J Pediatr Health Care 2003; 17:184-189.

Aziah MSN, Rosnah T, Mardziah A, Norzila MZ. Childhood atopic dermatitis: a measurement of quality of life and family impact. Med J Malaysia 2002; 57:329-339.

Berth-Jones J, Finlay AY, Zaki I, Tan B, Goodyear H, Lewis-Jones S, Corkg MJ, Bleeheng SS, Salek MS, Allenc MR, Friedmannd P, Harpere J, Campi RDR, Smith S, Graham-Browni RAC. Cyclosporine in severe childhood atopic dermatitis: a multicenter study. J Am Acad Dermatol 1996; 34:1016-1021. [CrossRef]

Lewis-Jones MS, Finlay AY. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995; 132:942-949. [CrossRef]

Faught J, Bierl C, Barton B, Kemp A. Stress in mothers of young children with eczema. Arch Dis Child 2007; 92:683-686. [CrossRef]

Sifneos PE. The prevalence of "alexithymic" characteristics in psychosomatic patients. Psychother Psychosom 1973; 22:255- 262. [CrossRef]

Taylor S, Thordarson DS, Maxfield L, Fedoroff IC, Lovell K, Ogrodniczuk J. Comparative efficacy, speed, and adverse effects of three PTSD treatments: exposure therapy, EMDR, and relaxation training. J Consult Clin Psychol 2003; 71:330-338. [CrossRef]